Sign up here for our daily coronavirus newsletter on what you need to know, andsubscribe to our Covid-19 podcast for the latest news and analysis.
theUniversity of Oxford andAstraZeneca Plc has begun recruiting more than 10,000 subjects for advanced human studies on one of the world’s fastest Covid-19 experimental vaccines.
A smaller portion of the test will broaden the age range of the tests to children 5 to 12 and adults 56 and older, according to adeclaration. The other, larger step will test the effectiveness of the vaccine in volunteers 18 years and older.
Businesses around the world are rushing to develop weapons to fight the pandemic that has cloistered large populations and struggling economies. AstraZeneca received a boost in its efforts to have the vaccine tested and ready to use when the United Statespromised as much as $ 1.2 billion towards development on Thursday.
Adult subjects in the studies will be randomly selected to receive one or two doses of the Oxford candidate or an already approved meningococcal vaccine for comparison.
Volunteers will be recruited from across the UK and will record their reactions in an electronic journal and attend some follow-up visits. Some will receive swabs to take samples at home.
The proposed Covid-19 vaccine is made from a weakened version of a common cold virus that has been genetically engineered to prevent it from developing in humans. More than 1,000 people have already received it in an early trial that began in April.
Astra plans to make up to 30 million doses available in Britain as early as September. Under its agreement with Astra, the United States could start receiving supplies as early as October.